These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31731035)

  • 1. Canine parvovirus prevention and prevalence: Veterinarian perceptions and behaviors.
    Kelman M; Barrs VR; Norris JM; Ward MP
    Prev Vet Med; 2020 Jan; 174():104817. PubMed ID: 31731035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine parvovirus prevention-What influence do socioeconomics, remoteness, caseload and demographics have on veterinarians' perceptions and behaviors?
    Kelman M; Barrs VR; Norris JM; Ward MP
    Prev Vet Med; 2020 Aug; 181():105065. PubMed ID: 32599371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
    Altman KD; Kelman M; Ward MP
    Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for death from canine parvoviral-related disease in Australia.
    Ling M; Norris JM; Kelman M; Ward MP
    Vet Microbiol; 2012 Aug; 158(3-4):280-90. PubMed ID: 22424864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine parvovirus in Australia: A comparative study of reported rural and urban cases.
    Zourkas E; Ward MP; Kelman M
    Vet Microbiol; 2015 Dec; 181(3-4):198-203. PubMed ID: 26530699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The geographic distribution and financial impact of canine parvovirus in Australia.
    Kelman M; Ward MP; Barrs VR; Norris JM
    Transbound Emerg Dis; 2019 Jan; 66(1):299-311. PubMed ID: 30242978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of CPV infection in vaccinated puppies that attended puppy socialization classes.
    Stepita ME; Bain MJ; Kass PH
    J Am Anim Hosp Assoc; 2013; 49(2):95-100. PubMed ID: 23325595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A history of canine parvovirus in Australia: what can we learn?
    Kelman M; Norris JM; Barrs VR; Ward MP
    Aust Vet J; 2020 Oct; 98(10):504-510. PubMed ID: 32754949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine parvovirus type 2 (CPV-2) serological and molecular patterns in dogs with viral gastroenteritis from southern Brazil.
    Truyen LH; Flores RS; de Oliveira Santana W; Abreu MB; Brambatti G; Lunge VR; Streck AF
    Braz J Microbiol; 2024 Jun; 55(2):1979-1986. PubMed ID: 38407780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the Canine Parvovirus 2c Subtype in Australian Dogs.
    Woolford L; Crocker P; Bobrowski H; Baker T; Hemmatzadeh F
    Viral Immunol; 2017 Jun; 30(5):371-376. PubMed ID: 28414634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Immunity and Seropositivity of IgG Antibodies to Canine Parvoviruses in Vaccinated and Unvaccinated Dogs in Abeokuta, Nigeria.
    Babalola ET; Ijaopo OK; Okonko IO
    J Immunoassay Immunochem; 2016; 37(1):16-28. PubMed ID: 25891124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine viral vaccines at a turning point--a personal perspective.
    Carmichael LE
    Adv Vet Med; 1999; 41():289-307. PubMed ID: 9890023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?
    Decaro N; Buonavoglia C; Barrs VR
    Vet Microbiol; 2020 Aug; 247():108760. PubMed ID: 32768213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
    Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
    J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
    Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic, geographic and climatic risk factors for canine parvovirus infection and euthanasia in Australia.
    Kelman M; Barrs VR; Norris JM; Ward MP
    Prev Vet Med; 2020 Jan; 174():104816. PubMed ID: 31739219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
    Truyen U
    Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.